RxDoctor Payments DataLook up a doctor →

Kirk Wilcox, MD

Sports Medicine · Hixson, TNNPI 1831222835

Payments from drug & device makers

$14,299in general payments, 2019–2025

Across 861 payments — averaging $16.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$2K
  • AbbVie$1K
  • Pfizer$1K
  • Lilly USA, LLC$1K
  • Amgen$938
  • plus $6K from 44 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk125$2,179
AstraZeneca(2 entities)92$1,540
AbbVie(2 entities)95$1,342
Pfizer67$1,052
Lilly USA, LLC73$1,029
Amgen(2 entities)57$938
Boehringer Ingelheim54$844
Bayer34$701
Abbott25$479
Takeda Pharmaceuticals U.S.A., Inc.25$376
Merck23$337
Astellas Pharma US Inc15$314
GSK17$295
Amarin Pharma, Inc.14$270
Johnson & Johnson12$217
Biohaven Pharmaceutical Holding Company Ltd.8$172
E.r. Squibb & Sons, L.L.C.10$159
Esperion Therapeutics, Inc.8$153
Corium, LLC6$151
Kowa Pharmaceuticals America, Inc.9$141
Otsuka America Pharmaceutical, Inc.6$131
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$127
Xeris Pharmaceuticals, Inc.6$113
Sanofi-aventis U.S. LLC7$109
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$108
Dexcom, Inc.6$105
Shield Therapeutics Inc6$92
Eisai Inc.6$88
Jazz Pharmaceuticals Inc.4$87
Exact Sciences4$71
Novartis4$65
Arbor Pharmaceuticals, Inc.4$57
Neos Therapeutics, LP3$55
Axsome Therapeutics, Inc.2$45
Lundbeck LLC2$41
Azurity Pharmaceuticals, Inc.2$39
Sumitomo Pharma America, Inc.2$38
Phathom Pharmaceuticals, Inc.2$29
Almatica Pharma LLC2$27
Idorsia Pharmaceuticals US Inc2$27
Nevro Corp.1$25
Inspire Medical Systems, Inc.1$22
Amneal Pharmaceuticals LLC1$17
Antares Pharma, Inc.1$16
Dynavax Technologies Corporation1$15
Intra-sana Laboratories1$14
Pacira Therapeutics, Inc.1$14
IBSA Pharma Inc.1$13
Clarus Therapeutics Inc.1$12
Ironwood Pharmaceuticals, Inc1$11

How this compares

$14,299 in reported general payments places this provider in the 80th percentile of 147 sports medicine providers in Tennessee.

See all sports medicine providers in Tennessee →

Medicare billing

Part B allowed, 2024
$102,200
Medicare patients
375
Services billed
1,258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other sports medicine in Hixson

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →